Skip to main content
Premium Trial:

Request an Annual Quote

Lynx Adds Two Patents to Genomics IP Portfolio

Premium

H

AYWARD, Calif.--Lynx Therapeutics was recently issued a patent broadly covering its use of encoded adaptors in its Massively Parallel Signature Sequencing technology. The company has also acquired an exclusive worldwide license to a molecular tagging technology invented by George Church and Stephen Kieffer-Higgins at Harvard Medical School.

Norrie Russell, Lynx’s CEO, said the company’s intellectual property portfolio now includes 49 patents in the area of genomics, DNA analysis, and DNA chemistry. Said Russell, "Encoded adaptors are a key element of our MPSS technology since they increase the efficiently of the method by almost an order of magnitude." He added that the license to the Harvard technology broadens the reach of Lynx’s existing patents covering its Megaclone technology, which enables simultaneous manipulation and analysis of very complex mixtures of millions of DNA molecules or fragments.

Filed under

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.